SCHEMBL5265596

SCHEMBL5265596

COc1ccc2c(C(=O)O)snc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.48
ALDH1A1 P00352 6/20 0.48
HPGD P15428 4/20 0.48
HSD17B10 Q99714 2/20 0.48
LMNA P02545 2/20 0.48
POLB P06746 1/20 0.48
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA12 O43570 1/20 0.43
CA3 P07451 1/20 0.43
CA4 P22748 1/20 0.43
CA5A P35218 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
MAPK1 P28482 1/20 0.42
MAPT P10636 2/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4704635 0.89 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL5611010 0.84 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4703130 0.76 RXFP1 (0.41) KDM4EALDH1A1SMN1; SMN2NPC1DYRK1A
SCHEMBL22969068 0.75 KDM4E (0.53) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL261543 0.74 PRKAG1 (0.45) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL3984394 0.73 SMN1; SMN2 (0.42) KDM4EALDH1A1LMNAPOLBMAPT
SCHEMBL5611137 0.71 ALOX15 (0.45) KDM4EALDH1A1HPGDPOLBCA1
SCHEMBL5759973 0.71 LMNA (0.78) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL5611102 0.71 ACMSD (0.40) KDM4EPOLBSMN1; SMN2NPC1RAB9A
SCHEMBL260528 0.71 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828179-A2 NICOTINIC ALPHA-7 RECEPTOR LIGANDS AND PREPARATION AND USES THEREOF Memory Pharmaceutical Corporation (US) 2007-09-05 EP disclosed
EP-1745046-A2 1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZIOSOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF Memory Pharmaceuticals Corporation (US) 2007-01-24 EP disclosed
WO-2006069097-A2 NICOTINIC ALPHA-7 RECEPTOR LIGANDS AND PREPARATION AND USES THEREOF MEMORY PHARMACEUTICALS CORPORATION (US) 2006-06-29 WO disclosed
WO-2005111038-A2 1H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF MEMORY PHARMACEUTICALS CORPORATION (US) 2005-11-24 WO disclosed